News | December 03, 2006

Docs Should Alert ICD/Pacemaker Patients About Magnets

Magnets may interfere with the operation of pacemakers and implantable cardioverter defibrillators (ICDs), according to a study published in the December 2006 edition of “Heart Rhythm.”

A release from the Heart Rhythm Society reports that researchers found that while common magnets for home and office use with low magnetic strength posed little risk, stronger magnets made from neodymium-iron-boron (NdFeB) may cause interference with cardiac devices and pose potential hazards to patients. NdFeB magnets are increasingly being used in homes and office products, toys, jewelry and even clothing.

“Physicians should caution patients about the risks associated with these magnets,” says Thomas Wolber, a cardiologist at the University Hospital of Zurich in Switzerland and lead author of the study. “We also recommend that the packaging include information on the potential risks that may be associated with these types of magnets.”

Two spherical magnets of eight and 10 millimeters in diameter and one necklace made of 45 spherical magnets were tested on 70 patients, 41 with pacemakers and 29 with ICDs. Magnetic interference was observed in all patients. The cardiac devices resumed normal function after the magnets were removed.

“This study is timely and important to attract the attention of both the public and the medical profession about the potentially serious health consequences of magnets used in decoration products... for an ICD patient, the magnet interference can be fatal,” writes Huagui Li, M.D., a cardiologist at the Minnesota Heart Clinic in Edina, MN, in an accompanying “Heart Rhythm” editorial.

Dr. Li concludes that manufacturers who use magnets should be required to put warning labels on their products for optimal patient safety.


Related Content

News | Cardiovascular Clinical Studies

May 6, 2026 — Image Analysis Group (IAG), a global imaging CRO headquartered in London, U.K., and HeartcoR Solutions ...

Home May 06, 2026
Home
News | Cardiovascular Clinical Studies

April 9, 2026 — Mount Sinai researchers have created an analytic tool using machine learning that can predict ...

Home April 14, 2026
Home
News | Cardiovascular Clinical Studies

April 13, 2026 —The American Heart Association (AHA) has granted Case Western Reserve University the Rapid Impact ...

Home April 13, 2026
Home
News | Cardiovascular Clinical Studies

April 2, 2026 — Iterative Health and US Heart & Vascular (USHV) have announced a strategic partnership to advance ...

Home April 02, 2026
Home
News | Cardiovascular Clinical Studies

March 4, 2026 — UltraSight, a provider of AI-guided cardiac imaging workflows, has announced Late-Breaking clinical ...

Home March 04, 2026
Home
News | Cardiovascular Clinical Studies

Feb. 9, 2026 — HTA and MedAxiom have opened applications for the 2026 HeartX program, a cardiovascular-focused ...

Home February 18, 2026
Home
News | Cardiovascular Clinical Studies

Jan. 5, 2026 — Medera Inc., a clinical-stage biopharmaceutical company focused on targeting cardiovascular diseases by ...

Home January 05, 2026
Home
News | Cardiovascular Clinical Studies

Nov. 10, 2025 —Genomics, a science-led techbio company, has today announced new research that suggests polygenic risk ...

Home November 12, 2025
Home
News | Cardiovascular Clinical Studies

Oct. 21, 2025 – AskBio Inc., a gene therapy company wholly owned and independently operated as a subsidiary of Bayer AG ...

Home October 21, 2025
Home
News | Cardiovascular Clinical Studies

Aug. 25, 2025 — Merck, known as MSD outside of the United States and Canada, has announced that new clinical trial and ...

Home August 25, 2025
Home
Subscribe Now